Drug or treatment

Mogamulizumab clinical trials

• 10Clinical trials
• 9Countries

Newest trials

All recruiting trials (10)

• Poteligeo (mogamulizumab) for adults with mycosis fungoides or Sézary syndrome

  This project will try Poteligeo (mogamulizumab) in adults with mycosis fungoides or Sézary syndrome who have had at least one prior systemic therapy to see how safe and effective it is in routine care in Korea.

  Recruiting at 5 sites Kyowa Kirin Co., Ltd. · Busan, Busan Metropolitan City and 5 other locations · NCT07132567

• Mogamulizumab-associated rash in people with mycosis fungoides or Sézary syndrome

  See if a rash that appears while taking mogamulizumab is a drug-related rash and how it links to treatment response in adults with relapsed or refractory mycosis fungoides or Sézary syndrome.

  Recruiting at 2 sites City of Hope Medical Center · Duarte, California and 9 other locations · NCT07003100

• Preventing Adult T-cell Leukemia/Lymphoma in People with HTLV-1

  This study is testing if a new drug called mogamulizumab can help prevent adult T-cell leukemia/lymphoma in adults who are infected with the HTLV-1 virus and are at higher risk for this cancer.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06698003

• Combining mogamulizumab with DA-EPOCH for aggressive T cell lymphoma treatment

  This study is testing if combining a new drug called mogamulizumab with a specific chemotherapy treatment can help people with aggressive T-cell lymphomas get better.

  Recruiting at 2 sites Phase 2 Yale University · New Haven, Connecticut and 1 other locations · NCT05996185

• Combining pembrolizumab and mogamulizumab for advanced cutaneous T-cell lymphomas

  This study is testing if combining two drugs, pembrolizumab and mogamulizumab, can help people with advanced cutaneous T-cell lymphomas that haven't responded to other treatments.

  Recruiting Phase 2 University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT05956041

• Treatment for erythrodermic cutaneous T cell lymphoma using photopheresis and mogamulizumab

  This study is testing a new treatment combining light therapy and a medication for people with a rare skin cancer called erythrodermic cutaneous T cell lymphoma to see if it helps them feel better and improves their quality of life.

  Recruiting Phase 2 City of Hope Medical Center · Scottsdale, Arizona and 2 other locations · NCT04930653

• Using natural killer cells and mogamulizumab to treat relapsed or refractory cutaneous T-cell lymphomas and adult T-cell leukemia/lymphoma

  This study is testing a new treatment using natural killer cells and mogamulizumab to see if it helps people with tough-to-treat skin lymphomas and adult T-cell leukemia feel better and live longer.

  Recruiting Phase 1 Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT04848064

• Combining mogamulizumab with low-dose total skin electron beam therapy for treating skin lymphomas

  This study is testing if combining a new drug called mogamulizumab with a special type of skin radiation therapy can help people with certain skin lymphomas feel better.

  Recruiting Phase 2 Stanford University · Stanford, California · NCT04256018

• Combining Mogamulizumab with Total Skin Electron Beam Therapy for Skin Lymphoma

  This study is testing if combining a new drug called Mogamulizumab with a special type of radiation therapy can help people with advanced skin lymphoma who haven't had success with other treatments.

  Recruiting at 13 sites Phase 2 European Organisation for Research and Treatment of Cancer - EORTC · Copenhagen and 12 other locations · NCT04128072

• Evaluating safety in patients with leukemia or lymphoma treated with mogamulizumab after stem cell transplantation

  This study is trying to see how safe the drug mogamulizumab is for people with certain types of leukemia or lymphoma after they have a stem cell transplant.

  Recruiting Kyowa Kirin Co., Ltd. · Milwaukee, Wisconsin · NCT04014374

Quick answers

How many clinical trials of Mogamulizumab are recruiting right now?

10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in United States (8 trials), South Korea (1 trial), Denmark (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 6, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →